메지온 Stock: price and insider trades · South Korea

Every trade that managers of 메지온 disclose to DART (FSS) is tracked on this page. The company sits in the Health Care sector. Over the twelve months to 2 November 2026, 13 filings were filed, from 4 insiders.

Purchases and sales both appear in the filings: 10 purchases (3 insiders, €23k) and 3 sales (2 insiders). The totals exclude 12 filings filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. On the buying side, the filings list 2 senior executives and 1 chief executive among the declarants. One trade stands out by size: a purchase of €23k from 노성일, disclosed on 18 March 2026, or 0.0019% of market capitalisation.

The clock since the last published purchase (29 October 2026) now reads 12 days. The median gap between a trade and its publication by DART (FSS) is 1 day. That lag is the time during which only the insider knows about the trade.

Across the 2,655 companies tracked on its exchange, the median is 7 filings; at 13 filings, this issuer sits above that mark. Our records for 메지온 go back to 2021, with 21 purchases and 5 sales on the open market in total.

Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and UCB. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.